An in-vitro study on regeneration of human nucleus pulposus by using gelatin/chondroitin-6-sulfate/hyaluronan tri-copolymer scaffold.

Tissue engineering approaches for treating degenerative intervertebral discs aim to promote tissue regeneration then retard or even reverse the degenerative process. A gelatin/chondroitin-6-sulfate/hyaluronan tri-copolymer was developed to serve as a bioactive scaffold that could help human nucleus pulposus (NP) cells to preserve their cell viability/proliferation and promote matrix synthesis. Each scaffold was seeded with 1 x 10(6) monolayer-expanded human NP cells and then cultured in vitro. Over a 4-week cultivation period, cell-scaffold hybrids demonstrated active cell viability/proliferation and a progressive increase in net production of glycosaminoglycans. In comparison to monolayer cells, scaffold-cultured cells showed significantly higher mRNA expression in collagen II, aggrecan, Sox9, TGFbeta1, and TIMP1. Expression of mRNA was significantly suppressed in collagen I, collagen X, IL1, and Fas-associating death domain protein. Histological studies showed newly synthesized glycosaminoglycans deposits and collagen II in scaffolds. These results indicate that the tri-copolymer scaffold could be considered as a promising bioactive scaffold for regenerating human NP.

[1]  C. Perka,et al.  Cultivation of porcine cells from the nucleus pulposus in a fibrin/hyaluronic acid matrix , 2000, Acta orthopaedica Scandinavica.

[2]  M. Aebi,et al.  The Potential and Limitations of a Cell-Seeded Collagen/Hyaluronan Scaffold to Engineer an Intervertebral Disc-Like Matrix , 2003, Spine.

[3]  M. Spector,et al.  Proteoglycans synthesized by canine intervertebral disc cells grown in a type I collagen-glycosaminoglycan matrix. , 2002, Tissue engineering.

[4]  M. Bayliss,et al.  The Large Proteoglycans of the Human Intervertebral Disc: Changes in Their Biosynthesis and Structure with Age, Topography, and Pathology , 1995, Spine.

[5]  S. Roberts,et al.  Type X collagen in the human invertebral disc: an indication of repair or remodelling? , 1998, The Histochemical Journal.

[6]  M. Aebi,et al.  The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. , 1996, The Journal of clinical investigation.

[7]  Freddie H. Fu,et al.  GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. , 2000, Journal of biomedical materials research.

[8]  H J Mankin,et al.  Articular cartilage: tissue design and chondrocyte-matrix interactions. , 1998, Instructional course lectures.

[9]  J. Adler,et al.  Degeneration of the intervertebral disks and spondylosis in aging sand rats. , 1979, Archives of pathology & laboratory medicine.

[10]  J. P. Thompson,et al.  Stimulation of Mature Canine Intervertebral Disc by Growth Factors , 1991, Spine.

[11]  J. Zerwekh,et al.  Biochemical changes associated with the symptomatic human intervertebral disk. , 1993, Clinical orthopaedics and related research.

[12]  J. Turnay,et al.  Gelatinases in soft tissue biomaterials. Analysis of different crosslinking agents. , 2002, Biomaterials.

[13]  A. Rowan,et al.  The Regulation of MMPs and TIMPs in Cartilage Turnover , 1999, Annals of the New York Academy of Sciences.

[14]  T. Kikuchi,et al.  The role of interleukin-1 on proteoglycan metabolism of rabbit annulus fibrosus cells cultured in vitro. , 1988, Spine.

[15]  J. Adler,et al.  Early Onset of Disk Degeneration and Spondylosis in Sand Rats (Psammomys Obesus) , 1983, Veterinary pathology.

[16]  Freddie H. Fu,et al.  GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesisNo benefit of any kind will be received either directly or indirectly by the authors. , 2000 .

[17]  B. Caterson,et al.  Matrix Metalloproteinases And Aggrecanase: Their Role in Disorders of the Human Intervertebral Disc , 2000, Spine.

[18]  G. Waddell.  Low Back Pain: A Twentieth Century Health Care Enigma , 1996, Spine.

[19]  P. Roughley.  Biology of Intervertebral Disc Aging and Degeneration: Involvement of the Extracellular Matrix , 2004, Spine.

[20]  T. Ganey,et al.  A potential role for cell-based therapeutics in the treatment of intervertebral disc herniation , 2002, European Spine Journal.

[21]  M. Ishihara,et al.  An atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) for the culture of annulus fibrosus cells from an intervertebral disc. , 2003, Journal of biomedical materials research. Part A.

[22]  S. Ayad,et al.  1991 Volvo Award in Basic Sciences: Collagen Types Around the Cells of the Intervertebral Disc and Cartilage End Plate: An Immunolocalization Study , 1991, Spine.

[23]  A. Freemont,et al.  Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy , 2002, The Journal of pathology.

[24]  M. Lotz,et al.  Fas/Fas ligand expression and induction of apoptosis in chondrocytes. , 1997, Arthritis and rheumatism.

[25]  J A Buckwalter,et al.  Aging and degeneration of the human intervertebral disc. , 1995, Spine.

[26]  J. Mochida,et al.  The Importance of Preserving Disc Structure in Surgical Approaches to Lumbar Disc Herniation , 1996, Spine.

[27]  N. Adachi,et al.  Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels , 1999, Journal of cellular physiology.